# Anaptys Appoints Chris Murphy as Chief Financial Officer and Owen Hughes to Board of Directors
Canonical URL: https://biopharmsignal.com/news/ANAB/anaptys-appoints-chris-murphy-as-chief-financial-officer-and-owen-hughes-to-board-of-directors
Ticker: ANAB
Company: AnaptysBio, Inc.
Source: AnaptysBio, Inc.
Published: 2026-05-11 13:15 EST
Original Source URL: https://ir.anaptysbio.com
## Summary

Strengthens Leadership Team and Board with additional business development, finance and royalty management expertise SAN DIEGO, May 11, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a company focused on managing the financial collaborations for Jemperli with GSK and imsidolimab with

## Article Body
Strengthens Leadership Team and Board with additional business development, finance and royalty management expertise SAN DIEGO, May 11, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a company focused on managing the financial collaborations for Jemperli with GSK and imsidolimab with
## Recent Company News
- 2026-05-12 20:15 EST — [Anaptys Announces First Quarter 2026 Financial Results and Provides Business Update](https://biopharmsignal.com/news/ANAB/anaptys-announces-first-quarter-2026-financial-results-and-provides-business-update) — Source: AnaptysBio, Inc.
- 2026-05-11 13:15 EST — [Anaptys Appoints Chris Murphy as Chief Financial Officer and Owen Hughes to Board of Directors](https://biopharmsignal.com/news/ANAB/anaptys-appoints-chris-murphy-as-chief-financial-officer-and-owen-hughes-to-board-of-directors) — Source: AnaptysBio, Inc.
- 2026-05-04 20:15 EST — [Anaptys to Participate at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference](https://biopharmsignal.com/news/ANAB/anaptys-to-participate-at-the-h-c-wainwright-2nd-annual-royalty-company-virtual-conference) — Source: AnaptysBio, Inc.
- 2026-04-24 19:40 EST — [Delaware Chancery Court Rules in Favor of Anaptys by Dismissing Tesaro’s Anticipatory Breach Claim](https://biopharmsignal.com/news/ANAB/delaware-chancery-court-rules-in-favor-of-anaptys-by-dismissing-tesaro-s-anticipatory-breach-claim) — Source: AnaptysBio, Inc.
- 2026-04-20 13:15 EST — [Anaptys Completes Separation of First Tracks Biotherapeutics and Now Exclusively Manages GSK and Vanda Financial Collaborations](https://biopharmsignal.com/news/ANAB/anaptys-completes-separation-of-first-tracks-biotherapeutics-and-now-exclusively-manages-gsk-and-vanda-financial-collaborations) — Source: AnaptysBio, Inc.
## Related News
- 2026-07-21 20:15 EST — BFRG — [BullFrog AI to Participate in Water Tower Research Fireside Chat on Thursday, July 23, 2026](https://biopharmsignal.com/news/BFRG/bullfrog-ai-to-participate-in-water-tower-research-fireside-chat-on-thursday-jul-78357ce8)
- 2026-07-21 20:05 EST — CLPT — [ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026](https://biopharmsignal.com/news/CLPT/clearpoint-neuro-to-announce-second-quarter-2026-results-august-3-2026-6e4f3c05)
- 2026-07-21 20:05 EST — TCMD — [Tactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026](https://biopharmsignal.com/news/TCMD/tactile-medical-to-release-second-quarter-of-fiscal-year-2026-financial-results--798d4004)
- 2026-07-21 20:05 EST — PIII — [P3 Health Partners Schedules Second Quarter 2026 Earnings Release and Conference Call](https://biopharmsignal.com/news/PIII/p3-health-partners-schedules-second-quarter-2026-earnings-release-and-conference-6c9bd8a7)
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)